Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Atopic Eczema”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04086121
What this trial is testing

Test the Long-term Safety of BI 655130 in Patients With Atopic Eczema Who Took Part in Study 1368-0032

Who this might be right for
Dermatitis, Atopic
Boehringer Ingelheim 14
Not applicableUnknownNCT05318300
What this trial is testing

Evaluation of an Adapted Formula on Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
United Pharmaceuticals 126
Large-scale testing (Phase 3)Study completedNCT04345367
What this trial is testing

Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

Who this might be right for
Atopic Dermatitis
Pfizer 727
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06756126
What this trial is testing

A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Akeso 24
Not applicableEnded earlyNCT05250115
What this trial is testing

Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 112
Not applicableStudy completedNCT05214326
What this trial is testing

Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf Countries

Who this might be right for
Dermatitis Atopic
Sanofi 187
Early research (Phase 1)Study completedNCT07336940
What this trial is testing

Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Enveda Therapeutics 9
Large-scale testing (Phase 3)Study completedNCT00523952
What this trial is testing

Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients

Who this might be right for
Dermatitis, Atopic
Astellas Pharma Inc 303
Early research (Phase 1)Looking for participantsNCT07693738
What this trial is testing

A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
AD
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 96
Large-scale testing (Phase 3)Study completedNCT06224192
What this trial is testing

A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amgen 151
Testing effectiveness (Phase 2)Study completedNCT05656911
What this trial is testing

Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Bayer 77
Early research (Phase 1)Study completedNCT06553209
What this trial is testing

Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Keymed Biosciences Co.Ltd 110
Post-approval studies (Phase 4)Study completedNCT04033367
What this trial is testing

SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"

Who this might be right for
Atopic Dermatitis
Sanofi 188
Testing effectiveness (Phase 2)Study completedNCT06790121
What this trial is testing

Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Dermatitis Atopic
Sanofi 150
Large-scale testing (Phase 3)Looking for participantsNCT06389136
What this trial is testing

Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Who this might be right for
Atopic Dermatitis
AbbVie 200
Testing effectiveness (Phase 2)Study completedNCT01859988
What this trial is testing

Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 380
Large-scale testing (Phase 3)Study completedNCT03796676
What this trial is testing

JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer 287
Testing effectiveness (Phase 2)Study completedNCT04021862
What this trial is testing

Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisEczema
Janssen Research & Development, LLC 87
Testing effectiveness (Phase 2)Ended earlyNCT05911841
What this trial is testing

LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 234
Testing effectiveness (Phase 2)Study completedNCT01552629
What this trial is testing

A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 22
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation